Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
CA$0.25 - CA$1.11
Next Earnings Date
May 05 2025
Next Earnings Date
May 05 2025
Latest price
Market Cap | CA$102.43M |
EV | CA$150.72M |
Shares Outstanding | 325.16M |
Beta | 2.67 |
Analyst Rating | BUY |
Analyst Target Price | CA$0.70 |
P/E 2025E | 2.84x |
P/Revenue 2025E | 0.57x |
Revenue | -0.90% |
EPS | -17.00% |
Operating Cash Flow | - |
Free Cash Flow | 53.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 50.15% |
Net Profit Margin 2025E | 10.77% |
ROE 2025E | - |
ROCE 2024 | -43.38% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
Planet 13 Holdings Inc.
PLTH
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Data Unavailable
Employees
1,000
Website
www.planet13.comIPO Date
2018-06-21
Headquarters
2548 West Desert Inn Road, Suite 100, Las Vegas, Nevada, 89109, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved